SANGAMO THERAPEUTICS, INC. Operating Lease, Payments
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Operating Lease, Payments of $6.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-12-31 was $1.70M, a 0.00% change year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-09-30 was $1.80M, a 12.50% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-06-30 was $1.70M, a 13.33% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for the quarter ending 2021-03-31 was $1.70M, a 6.25% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for fiscal 2025 was $6.40M, a 14.67% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for fiscal 2024 was $7.50M, a 2.74% increase from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for fiscal 2023 was $7.30M, a 27.72% decline from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. operating lease, payments for fiscal 2022 was $10.10M, a 46.38% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $6.40M 10-K · filed 2026-03-30 | |||
| 2024-12-31 | $7.50M 10-K · filed 2026-03-30 | |||
| 2023-12-31 | $7.30M 10-K · filed 2025-03-17 | |||
| 2022-12-31 | $10.10M 10-K · filed 2024-03-13 | |||
| 2021-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $3.50M derived: sum of 2 quarters · filed 2024-03-13 | $5.20M derived: sum of 3 quarters · filed 2024-03-13 | $6.90M 10-K · filed 2024-03-13 |
| 2021-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.50M derived: sum of 2 quarters · filed 2021-11-04 | $5.20M 10-Q · filed 2021-11-04 | $6.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.40M 10-Q · filed 2021-08-05 | $5.10M derived: sum of 3 quarters · filed 2023-02-23 | $6.70M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.70M 10-Q · filed 2021-05-04 | $3.40M derived: sum of 2 quarters · filed 2023-02-23 | $5.00M derived: sum of 3 quarters · filed 2023-02-23 | $6.50M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $3.30M derived: sum of 2 quarters · filed 2023-02-23 | $4.80M derived: sum of 3 quarters · filed 2023-02-23 | $6.40M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $3.10M derived: sum of 2 quarters · filed 2021-11-04 | $4.70M 10-Q · filed 2021-11-04 | $6.20M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.10M 10-Q · filed 2021-08-05 | $4.60M derived: sum of 3 quarters · filed 2021-08-05 | $5.50M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.60M 10-Q · filed 2021-05-04 | $3.10M derived: sum of 2 quarters · filed 2021-05-04 | $4.00M derived: sum of 3 quarters · filed 2021-05-04 | $4.60M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.40M derived: sum of 2 quarters · filed 2020-02-28 | $3.00M derived: sum of 3 quarters · filed 2020-02-28 | $3.50M 10-K · filed 2020-02-28 |
| 2019-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.50M derived: sum of 2 quarters · filed 2019-11-06 | $2.00M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.10M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $500.00K 10-Q · filed 2019-05-08 |